Tyra Biosciences, Inc. (TYRA) stock

TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30

$20.02+0.26 (+1.32%)

Close on Nov 13, 2026Market cap $1.20BP/E –Yield –

Tyra Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

Tyra Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?